Insufficient scRNA-seq data for expression of ZP3 at single-cell level.
Insufficient scRNA-seq data for expression of ZP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 223.26 | 177 / 180 | 100% | 15.51 | 428 / 430 |
prostate | 97% | 162.27 | 238 / 245 | 97% | 11.46 | 487 / 502 |
breast | 95% | 164.99 | 438 / 459 | 96% | 9.96 | 1070 / 1118 |
uterus | 98% | 131.56 | 166 / 170 | 93% | 9.41 | 426 / 459 |
bladder | 95% | 89.76 | 20 / 21 | 90% | 10.14 | 456 / 504 |
skin | 99% | 202.78 | 1784 / 1809 | 87% | 6.86 | 411 / 472 |
pancreas | 100% | 155.12 | 328 / 328 | 85% | 5.82 | 152 / 178 |
intestine | 92% | 129.93 | 893 / 966 | 92% | 13.44 | 487 / 527 |
esophagus | 89% | 157.26 | 1286 / 1445 | 92% | 7.07 | 169 / 183 |
kidney | 93% | 88.28 | 83 / 89 | 79% | 5.56 | 715 / 901 |
adrenal gland | 100% | 205.65 | 257 / 258 | 70% | 3.91 | 161 / 230 |
lung | 78% | 80.02 | 451 / 578 | 88% | 8.86 | 1014 / 1155 |
stomach | 86% | 76.88 | 307 / 359 | 77% | 9.64 | 220 / 286 |
thymus | 90% | 106.27 | 585 / 653 | 65% | 3.40 | 393 / 605 |
brain | 94% | 133.23 | 2483 / 2642 | 59% | 3.45 | 417 / 705 |
spleen | 100% | 146.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.46 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 95% | 7.74 | 76 / 80 |
adipose | 95% | 125.20 | 1139 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 107.77 | 837 / 929 | 0% | 0 | 0 / 0 |
liver | 44% | 24.22 | 99 / 226 | 39% | 1.88 | 157 / 406 |
blood vessel | 77% | 82.99 | 1026 / 1335 | 0% | 0 | 0 / 0 |
muscle | 53% | 58.86 | 422 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 2.40 | 15 / 29 |
heart | 50% | 51.28 | 434 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_2000386 | Biological process | positive regulation of ovarian follicle development |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_2000344 | Biological process | positive regulation of acrosome reaction |
GO_0007165 | Biological process | signal transduction |
GO_2000388 | Biological process | positive regulation of antral ovarian follicle growth |
GO_0002922 | Biological process | positive regulation of humoral immune response |
GO_0048599 | Biological process | oocyte development |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001809 | Biological process | positive regulation of type IV hypersensitivity |
GO_2000360 | Biological process | negative regulation of binding of sperm to zona pellucida |
GO_2000368 | Biological process | positive regulation of acrosomal vesicle exocytosis |
GO_0002687 | Biological process | positive regulation of leukocyte migration |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0001825 | Biological process | blastocyst formation |
GO_0002455 | Biological process | humoral immune response mediated by circulating immunoglobulin |
GO_0035803 | Biological process | egg coat formation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0035805 | Cellular component | egg coat |
GO_0031012 | Cellular component | extracellular matrix |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0035804 | Molecular function | structural constituent of egg coat |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0032190 | Molecular function | acrosin binding |
Gene name | ZP3 |
Protein name | Zona pellucida sperm-binding protein 3 (Zona pellucida glycoprotein 3) (Zona pellucida protein C) Zona pellucida sperm-binding protein 3 (Sperm receptor) (ZP3A/ZP3B) (Zona pellucida glycoprotein 3) (Zp-3) (Zona pellucida protein C) [Cleaved into: Processed zona pellucida sperm-binding protein 3] |
Synonyms | ZPC ZP3A ZP3B |
Description | FUNCTION: Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy. The zona pellucida is composed of 3 to 4 glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation. FUNCTION: Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy. The zona pellucida is composed of 3 to 4 glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation. . FUNCTION: Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy. The zona pellucida is composed of 3 to 4 glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation. . |
Accessions | ENST00000336517.8 [P21754-3] ENST00000416245.5 E9PFI9 ENST00000394860.3 P21754 ENST00000394857.8 [P21754-1] H0Y3M4 |